Gene · 1213
Papers3,108
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,108
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mass Spectrometry-Based Proteomics of Human Milk to Identify Differentially Expressed Proteins in Women with Breast Cancer versus Controls. | Proteomes | 2022 | 36412635 | PubTator, text mining | PubMed |
| Immunomodulatory effect of extracellular vesicles from Entamoeba histolytica trophozoites: Regulation of NETs and respiratory burst during confrontation with human neutrophils. | Front Cell Infect Microbiol | 2022 | 36389143 | PubTator, text mining | PubMed |
| PCSK9 Inhibition and Risk of Diabetes: Should We Worry? | Curr Atheroscler Rep | 2022 | 36383291 | PubTator, text mining | PubMed |
| Differential impact of ubiquitous and muscle dynamin 2 isoforms in muscle physiology and centronuclear myopathy. | Nat Commun | 2022 | 36369230 | PubTator, text mining | PubMed |
| Self-efficacy and positive thinking as predictors of health-related quality of life in women with stress urinary incontinence. | BMC Womens Health | 2022 | 36368983 | PubTator, text mining | PubMed |
| Tocotrienol-Rich Fraction and Levodopa Regulate Proteins Involved in Parkinson's Disease-Associated Pathways in Differentiated Neuroblastoma Cells: Insights from Quantitative Proteomic Analysis. | Nutrients | 2022 | 36364894 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies. | Cancers (Basel) | 2022 | 36358625 | PubTator, text mining | PubMed |
| Immune cells transcriptome-based drug repositioning for multiple sclerosis. | Front Immunol | 2022 | 36341423 | PubTator, text mining | PubMed |
| Ovarian tumorB1-mediated heat shock transcription factor 1 deubiquitination is critical for glycolysis and development of endometriosis. | iScience | 2022 | 36339263 | PubTator, text mining | PubMed |
| WNK kinases sense molecular crowding and rescue cell volume via phase separation. | Cell | 2022 | 36318922 | PubTator, text mining | PubMed |
| H-TEX-mediated signaling between hepatocellular carcinoma cells and macrophages and exosome-targeted therapy for hepatocellular carcinoma. | Front Immunol | 2022 | 36311698 | PubTator, text mining | PubMed |
| The status of industrialization and development of exosomes as a drug delivery system: A review. | Front Pharmacol | 2022 | 36304147 | PubTator, text mining | PubMed |
| Hydroxyl-Rich Hydrophilic Endocytosis-Promoting Peptide with No Positive Charge. | J Am Chem Soc | 2022 | 36301712 | PubTator, text mining | PubMed |
| Whole Exome Sequencing and In Silico Analysis of Human Sertoli in Patients with Non-Obstructive Azoospermia. | Int J Mol Sci | 2022 | 36293429 | PubTator, text mining | PubMed |
| CEMIP, a Promising Biomarker That Promotes the Progression and Metastasis of Colorectal and Other Types of Cancer. | Cancers (Basel) | 2022 | 36291875 | PubTator, text mining | PubMed |
| Exosomes Released by Corneal Stromal Cells Show Molecular Alterations in Keratoconus Patients and Induce Different Cellular Behavior. | Biomedicines | 2022 | 36289615 | PubTator, text mining | PubMed |
| SARS-CoV-2 down-regulates ACE2 through lysosomal degradation. | Mol Biol Cell | 2022 | 36287912 | PubTator, text mining | PubMed |
| Phosphoinositide species and filamentous actin formation mediate engulfment by senescent tumor cells. | PLoS Biol | 2022 | 36279312 | PubTator, text mining | PubMed |
| Novel serum proteomic biomarkers for early diagnosis and aggressive grade identification of prostate cancer. | Front Oncol | 2022 | 36276156 | PubTator, text mining | PubMed |
| Self-assembly and structure of a clathrin-independent AP-1:Arf1 tubular membrane coat. | Sci Adv | 2022 | 36269825 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1213/papers?page=19